News

  • 24 November 2011

    Pfizer to buy Excaliard Pharmaceuticals

    Pfizer has entered into a definitive agreement to acquire Excaliard Pharmaceuticals, gaining access to EXC 001, a skin scarring treatment.

  • 24 November 2011

    UK switches HPV vaccine supplier

    The UK will switch to using Merck's Gardasil vaccine instead of GlaxoSmithKline's rival product Cervarix to prevent girls from contracting the HPV virus, which can cause cervical cancer.

  • 23 November 2011

    Pfizer to sell Lipitor at generic prices

    Pfizer is planning to sell cholesterol drug Lipitor directly to patients at generic prices once the company loses patent protection, in an attempt to retain sales.

  • 22 November 2011

    FDA grants clearance for Tonix to begin TNX-102 study

    Tonix Pharmaceuticals has received US Food Drug and Administration (FDA) approval to initiate a comparative pharmacokinetic and bioavailability study of TNX-102, an oral formulation of cyclobenzaprine for the treatment of...

  • 22 November 2011

    Regeneron Eylea injection wins FDA nod

    The US Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals' Eylea (aflibercept) injection for the treatment of patients with neovascular (wet) age-related macular degeneration.

  • 22 November 2011

    Merck settles Vioxx lawsuit in the US

    Merck has agreed to pay a $950m fine to settle criminal and civil charges that it misrepresented the safety of its anti-inflammatory drug Vioxx.

Close
Close
Close

Go Top